apalutamide,pembrolizumab,atezolizumab,nivolumab,ipilimumab
janssen,bms,merck,roche
['cm-914', 'pembro', 'atezo', 'kn564', 'rcc,(-irccs),(-srcc),(-urcc)', 'immotion010', 'renal,(-adrenal)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'apa ', 'sarcoma', 'nivo']
fantastic speech by at #gu23 about adjuvant treatment in localized renal cell carcinoma. addition of pembrolizumab for adjuvant treatment for rcc is a welcome addition... but it's likely not for everyone #renalcancer 
Jefe de Servicio de Oncología Médica. Hospital Universitario Lucus Augusti, HULA. Grupo de Investigación Oncológica Traslacional, GIOT HULA. Cuenta personal